NRIX Berita Valas

Nurix Therapeutics Says Gilead Sciences Extends Ongoing Strategic Collaboration By Addl. Two Years

Biopharmaceutical company Nurix Therapeutics, Inc. (NRIX) announced Tuesday that Gilead Sciences, Inc. (GILD) has elected to extend the research term of the companies' ongoing collaboration, originally established in 2019, by an additional two years.

RTTNews | 506 days ago

Gilead Exercises Option To License Nurix's Protein Degrader Molecule NX-0479

Biopharmaceutical companies Gilead Sciences, Inc. (GILD) and Nurix Therapeutics, Inc. (NRIX) announced Monday that Gilead has exercised its option to exclusively license Nurix's investigational targeted protein degrader molecule NX-0479.

RTTNews | 885 days ago

Terms | Privacy | Site Map | Site Map Calendar

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.

EURUSD	1.16551	GBPUSD	1.34673	AUDUSD	0.64309
USDJPY	147.856	USDCAD	1.38801	USDCHF	0.80578